Key result
Extracellularly applied lysophosphatidylcholine (10 micromol/l) significantly augmented Cav3.2 but not Cav3.1 T-type Ca2+ channel currents in HEK-293 cells, possibly via protein kinase C signaling.
Extracellularly applied LPC augments Cav3.2 but not Cav3.1 T-type Ca2+ channel currents, possibly via protein kinase C signaling.
Lysophosphatidylcholine (LPC) has been shown to induce electrophysiological disturbances to arrhythmogenesis. However, the effects of LPC on the low-voltage-activated T-type Ca(2+) channels in the heart are not understood yet. We found that LPC increases the T-type Ca(2+) channel current (I(Ca.T)) in neonatal rat cardiomyocytes. To further investigate the underlying modulatory mechanism of LPC on T-type Ca(2+) channels, we utilized HEK-293 cells stably expressing alpha1G and alpha1H subunits (HEK-293/alpha1G and HEK-293/alpha1H), by use of patch-clamp techniques. A low concentration of LPC (10 micromol/l) significantly increased Ca(v)3.2 I(Ca.T) (alpha1H) that were similar to those observed in neonatal rat cardiomyocytes. Activation and steady-state inactivation curves were shifted in the hyperpolarized direction by 5.1 +/- 0.2 and 4.6 +/- 0.4 mV, respectively, by application of 10 micromol/l LPC. The pretreatment of cells with a protein kinase C inhibitor (chelerythrine) attenuated the effects of LPC on I(Ca.T) (alpha1H). However, the application of LPC failed to modify Ca(v)3.1 (alpha1G) I(Ca.T) at concentrations of 10-50 micromol/l. In conclusion, these data demonstrate that extracellularly applied LPC augments Ca(v)3.2 I(Ca.T) (alpha1H) but not Ca(v)3.1 I(Ca.T) (alpha1G) in a heterologous expression system, possibly by modulating protein kinase C signaling.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2006) studied this question. Lysophosphatidylcholine (LPC) was evaluated on T-type Ca2+ channel current (I(Ca.T)). Extracellularly applied lysophosphatidylcholine (10 micromol/l) significantly augmented Cav3.2 but not Cav3.1 T-type Ca2+ channel currents in HEK-293 cells, possibly via protein kinase C signaling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: